Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
President of Novartis Institutes for BioMedical Research (NIBR)
James (Jay) Bradner, M.D.
Head of Global Drug Development and Chief Medical Officer for Novartis
John Tsai, M.D.
Other Members of Senior Management
Global Head of Novartis Business Assurance & Advisory and Head of Internal Audit
Natacha Theytaz
